Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2012 1
2013 3
2014 3
2015 2
2016 2
2018 2
2019 4
2020 8
2021 4
2022 6
2023 10
2024 6
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for chaulagain c
Search for Chaualgain C instead (1 results)
Systemic AL amyloidosis: current approach and future direction.
Bou Zerdan M, Nasr L, Khalid F, Allam S, Bouferraa Y, Batool S, Tayyeb M, Adroja S, Mammadii M, Anwer F, Raza S, Chaulagain CP. Bou Zerdan M, et al. Among authors: chaulagain cp. Oncotarget. 2023 Apr 26;14:384-394. doi: 10.18632/oncotarget.28415. Oncotarget. 2023. PMID: 37185672 Free PMC article. Review.
Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study.
Badros A, Foster L, Anderson LD Jr, Chaulagain CP, Pettijohn E, Cowan AJ, Costello C, Larson S, Sborov DW, Shain KH, Silbermann R, Shah N, Chung A, Krevvata M, Pei H, Patel S, Khare V, Cortoos A, Carson R, Lin TS, Voorhees P. Badros A, et al. Among authors: chaulagain cp. Blood. 2025 Jan 16;145(3):300-310. doi: 10.1182/blood.2024025746. Blood. 2025. PMID: 39331724 Free PMC article. Clinical Trial.
Adjuvant therapy of pancreatic cancer.
Chaulagain CP, Ng J, Goodman MD, Saif MW. Chaulagain CP, et al. JOP. 2013 Mar 10;14(2):119-22. doi: 10.6092/1590-8577/1461. JOP. 2013. PMID: 23474550 Free article. Review.
Treatment of relapsed multiple myeloma: Evidence-based recommendations.
Durer C, Durer S, Lee S, Chakraborty R, Malik MN, Rafae A, Zar MA, Kamal A, Rosko N, Samaras C, Valent J, Chaulagain C, Anwer F. Durer C, et al. Among authors: chaulagain c. Blood Rev. 2020 Jan;39:100616. doi: 10.1016/j.blre.2019.100616. Epub 2019 Aug 31. Blood Rev. 2020. PMID: 31500848 Review.
A Synopsis Clonal Hematopoiesis of Indeterminate Potential in Hematology.
Bou Zerdan M, Nasr L, Saba L, Meouchy P, Safi N, Allam S, Bhandari J, Chaulagain CP. Bou Zerdan M, et al. Among authors: chaulagain cp. Cancers (Basel). 2022 Jul 28;14(15):3663. doi: 10.3390/cancers14153663. Cancers (Basel). 2022. PMID: 35954328 Free PMC article. Review.
Adhesion molecules in multiple myeloma oncogenesis and targeted therapy.
Bou Zerdan M, Nasr L, Kassab J, Saba L, Ghossein M, Yaghi M, Dominguez B, Chaulagain CP. Bou Zerdan M, et al. Among authors: chaulagain cp. Int J Hematol Oncol. 2022 Apr 26;11(2):IJH39. doi: 10.2217/ijh-2021-0017. eCollection 2022 Apr. Int J Hematol Oncol. 2022. PMID: 35663420 Free PMC article. Review.
Liquid biopsies and minimal residual disease in lymphoid malignancies.
Bou Zerdan M, Kassab J, Saba L, Haroun E, Bou Zerdan M, Allam S, Nasr L, Macaron W, Mammadli M, Abou Moussa S, Chaulagain CP. Bou Zerdan M, et al. Among authors: chaulagain cp. Front Oncol. 2023 May 9;13:1173701. doi: 10.3389/fonc.2023.1173701. eCollection 2023. Front Oncol. 2023. PMID: 37228488 Free PMC article. Review.
49 results